Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Preliminary — small human trials with real but modest and inconsistent effects
What RhythmONE Claims To Be
RhythmONE is marketed under a longevity banner, but the actual sales copy is narrower than that: it is a stimulant-free liquid formula aimed at memory, focus, and mental clarity, taken as two droppers each morning. The pitch is explicitly slow-burn — the company says benefits accumulate over weeks rather than showing up the afternoon you start.
That framing is at least honest about what herbal nootropics do. Nothing in this category produces a caffeine-style jolt, and a product promising one would be more suspicious, not less.
What’s Actually In It
The official product page names five ingredients:
- Lion’s mane mushroom (Hericium erinaceus)
- Bacopa monnieri
- Shilajit extract
- Schisandra fruit extract
- Gotu kola (Centella asiatica)
A wrinkle worth flagging: third-party review pages circulating for this product list a different set of ingredients — ginkgo, phosphatidylserine, omega-3s, B12 — that do not match the official page. Those pages appear to be describing a generic brain supplement rather than this one. Treat any ingredient list you see off the official site with suspicion, and note that no per-ingredient doses are published anywhere, which is the single biggest problem with evaluating this formula against the research below.
What The Research Shows
According to PubMed, the human evidence for these herbs is real but thin, and it does not all point the same way.
Lion’s mane improved reaction time in a controlled trial — modestly. In a randomized, double-blind, placebo-controlled crossover study, participants took 1 g of Nordic-grown lion’s mane and completed neuropsychological tests at 1 and 2 hours. Lion’s mane significantly improved performance on the Serial 7s task, N-Back reaction time, and Go-stimulus reaction time versus placebo. Notably, the comparator arm in that same study — a guayusa tea extract — beat lion’s mane on most subjective measures, so this is not a knockout result. DOI
A 28-day lion’s mane study found a speed benefit and not much else. A double-blind parallel-groups pilot gave 41 healthy adults aged 18–45 either 1.8 g of lion’s mane or placebo. A single dose produced faster Stroop task performance at 60 minutes, and a reduction in subjective stress over 28 days approached but did not reach significance (p = 0.051). The authors were candid that “null and limited negative findings were also observed” and that the sample was too small to draw firm conclusions. DOI
Bacopa’s strongest negative finding deserves airtime. A systematic review of randomized controlled trials examined Bacopa monnieri for dementia and mild cognitive impairment due to Alzheimer disease. Five eligible trials, all judged at high risk of bias, produced very low certainty evidence — and the reviewers’ bottom line was that there was no difference between bacopa and placebo or donepezil. No major safety problems, but no demonstrated benefit in that population either. DOI
In healthy or mildly impaired older adults, bacopa-containing formulas have done better. A double-blind crossover trial in 30 elderly subjects with self-perceived cognitive decline used a combination containing bacopa, L-theanine, saffron, copper, folate, and B and D vitamins for two months. Mini-Mental State Examination and Perceived Stress Questionnaire scores improved significantly versus both baseline and the placebo arm. The obvious caveat: this was a multi-ingredient blend, so you cannot attribute the result to bacopa alone. DOI
Shilajit has human trial data, but not for memory. A 12-week randomized, double-blind, placebo-controlled trial in 166 sedentary adults with metabolic syndrome risk factors included shilajit as part of a chromium and fruit-extract combination alongside exercise and diet. Researchers saw signals on insulin sensitivity, blood lipids, and vascular measures — genuine findings, but cardiometabolic ones. There is no comparable cognitive trial supporting shilajit’s “reduces mental fatigue” claim on the product page. DOI
The Honest Verdict
What holds up: Lion’s mane has two independent randomized trials showing faster reaction time and processing speed in healthy adults. That is a legitimate, if narrow, effect — and it is the kind of thing a nootropic ingredient can plausibly deliver. Bacopa has decades of use and features in a supportive result in older adults with subjective decline — though that trial tested a multi-ingredient blend, so the credit cannot be assigned to bacopa alone. The safety record across all these trials is uneventful.
What doesn’t: The effect sizes are small and the study populations are small. The lion’s mane pilot explicitly reported null results alongside its positive ones. Bacopa flatly failed in the Alzheimer’s systematic review — if you are buying this hoping to address diagnosed cognitive impairment, the evidence says it will not do that. Shilajit’s cognitive claim on the label is not backed by cognitive trials. And the missing dose disclosure is not a small issue: the lion’s mane trials used 1 g and 1.8 g daily, and a liquid dropper formula splitting five herbs across 2 mL is unlikely to hit those numbers.
Who this makes sense for: A generally healthy adult who wants a low-risk, slow-acting addition to sleep, exercise, and the other things that actually move cognition, and who understands they are buying a modest reaction-time effect rather than a memory overhaul.
Who should skip it: Anyone with diagnosed cognitive impairment or dementia — the bacopa review speaks directly to that and the answer was no. Anyone unwilling to buy a formula that will not tell them how much of anything they are getting. And anyone on medication, since bacopa and shilajit both warrant a conversation with a pharmacist first.
Check current pricing and availability
View RhythmONE on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed: